price jul usd
buy rate reect view compani lever
pull margin expans avenu deploy capit life
scienc tool diagnost compani believ out-performance
announc dental spin support view
thing like
revis guidanc seem conserv set stock well
upwardli revis fy guidanc organ sale growth
adjust ep strike us conserv inde
organ sale growth guidanc mid-singl digit vs rang
begin year seem conserv light out-performance
anticip sale growth acceler multipl busi includ
pall strong order book growth last quarter cepheid unfavor
comp dental saw earli sign market stabil
better-than-expect growth recent acquir integr dna
technolog also rais adjust ep guidanc rang
growth
out-performance across busi segment stronger sale
growth outlook share gain trend across multipl busi give us
condenc growth trajectori increas growth
outlook accordingli believ grow line tool
 dx industri growth rate trajectori becom visibl
spin dental busi
china strength continu cautiou rhetor reflect
conservat expect near-term pain point broad-
base china strength continu point fact escal
 china trade tension weigh top-lin growth
bode well tool player group manag
adopt increment cautiou tone around trade tension
believ reectiv eort maintain conservat
actual expect line sight meaning
direct headwind busi inde mid-single-digit
outlook versu expect april s/china-rel ep
headwind contempl guid stem cost relat
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
preemptiv countermeasur relat tari oppos expect
healthi biopharma end market inde double-digit biopharma
sale growth pall reect increas demand single-us product
addit busi serv end market includ
beckman life scienc sciex molecular devic track
sever piec posit dental news includ plan spin-off
came multipl posit news item relat dental busi
first compani announc plan spino busi
under-perform time believ
remov meaning overhang share addit announc
trend busi improv equip tradit
consum post rst quarter growth sinc compani
recent launch rst clear align product call spark australia
rais pt roll forward valuat framework
new pt reect ev/ebitda multipl appli ttm end
ebitda ex option forecast multipl in-lin
forecast ratio
period end expense/ incom expense/ incom ep share share sale cash flow oper cash cash deploy
period end asset cash account receiv expens current current equip intang asset liabil note payabl current portion lt account expens current lt liabil stockhold juli
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
